Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.3. Removed Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No visible changes to study details or page content.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 replaces Revision: v3.4.0 as a minor metadata update; this does not alter page content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations have been expanded to include numerous U.S. states and international sites (Madrid, Greater London), and the revision is updated to v3.3.3.SummaryDifference1%

- Check112 days agoChange DetectedPublications section text updated to say publications are automatically filled from PubMed and may not be about the study, with a revision tag showing v3.3.2. The previous wording implying PubMed sources was replaced.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.